SCHEMBL6154793

SCHEMBL6154793

CCCCCCCCCOC(=O)CC(O)CC(=O)OCCCCCCCCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.64
NPSR1 Q6W5P4 2/20 0.55
RAD52 P43351 1/20 0.55
DGKA P23743 1/20 0.53
FAAH O00519 1/20 0.53
HTR2C P28335 1/20 0.51
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
EPHX1 P07099 1/20 0.50
TSHR P16473 2/20 0.48
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.47
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153504 1.00 NAAA (0.64) NAAANPSR1RAD52DGKAFAAH
SCHEMBL6156113 1.00 NAAA (0.64) NAAANPSR1RAD52DGKAFAAH
SCHEMBL6154314 1.00 NAAA (0.64) NAAANPSR1RAD52DGKAFAAH
SCHEMBL10524939 1.00 NAAA (0.64) NAAANPSR1RAD52DGKAFAAH
SCHEMBL6154932 1.00 NAAA (0.64) NAAANPSR1RAD52DGKAFAAH
SCHEMBL6154556 0.98 NAAA (0.61) NAAANPSR1RAD52DGKAFAAH
SCHEMBL28108257 0.93 GPR84 (0.58) NAAANPSR1RAD52DGKAFAAH
SCHEMBL9742848 0.92 NAAA (0.60) NAAANPSR1RAD52DGKAFAAH
SCHEMBL9744289 0.92 NAAA (0.60) NAAANPSR1RAD52DGKAFAAH
SCHEMBL9744745 0.92 NAAA (0.60) NAAANPSR1RAD52DGKAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-06-02 US disclosed
EP-1500642-A1 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these OGDH, GLUL, ADSL NAAA 403/4885NPSR1 4485/4885RAD52 1788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.